Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Clinical Trial 36938

Stanford, CA 94305


Study Summary:

Understanding How Ketamine Brings About Rapid Improvement in OCD Symptoms

Obsessive-Compulsive Disorder (OCD) is a chronic and disabling disorder that costs the economy over $2 billion annually and represents a significant public health problem. This study builds on our discovery that a potent NMDA receptor antagonist, ketamine, has rapid (hours) and robust therapeutic effects in OCD and will help us understand how ketamine works to relieve repetitive thoughts and behaviors.

Purpose: To understand how new drug brings about rapid improvement in OCD symptoms.

This clinical study is funded by the  by the National Institute of Mental Health (NIMH).


Qualified Participants Must:

• Be between 18 and 55 years of age
• Have a primary diagnosis of OCD
• Have sufficient severity of OCD symptoms
• Have the ability to tolerate a treatment-free period
• You have the capacity to provide informed consent

You cannot participate if:
• You have a psychiatric or medical conditions that make participation unsafe
• You are pregnant of nursing female
• You have major medical or neurological problem
• You have metallic device or dental braces


Qualified Participants May Receive:

The Stanford Translational OCD Research Program is looking for adults 18-55 years old with OCD to take part in a study providing these possible benefits:
Free diagnostic evaluation
Free test of your memory and attention
Compensation up to $400 after study completion
Your choice of free OCD psychotherapy or pharmacology after study completion


Research Site Profile

View Clinic Profile